Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Structure Therapeutics Inc. Director's Dealing 2024

Jun 12, 2024

31940_dirs_2024-06-12_5c29c6b2-f5a7-4b1d-ac0d-39911a44b1c8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2024-06-10

Reporting Person: Stevens Raymond C (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-06-10 Ordinary Shares C 555000 Disposed 643346 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-06-10 American Depositary Shares $ C 185000 Acquired Ordinary Shares (555000) Direct
2024-06-10 American Depositary Shares $ S 185000 Disposed Ordinary Shares (555000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 1554586 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
American Depositary Shares $ Ordinary Shares (12000) 4000 Indirect

Footnotes

F1: The Ordinary Shares were converted into American Depositary Shares as reported in Table II above.

F2: By Raymond Stevens and Vivian Urena-Stevens, as Co-Trustees of the Stevens 2001 Revocable Trust, dated March 28, 2001.

F3: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.

F4: The weighted average sale price for the transaction was $52.7965, and the range of prices was $52.43 and $53.075. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.